EncepHeal Therapeutics enhances the development of first-in-class medicines to improve treatment of mental health disorders.
EncepHeal Therapeutics has raised $150K in total funding. The most recent round was Debt Financing. The last funding was announced in July 2021.
EncepHeal Therapeutics's investors include Y Combinator, North Carolina Biotechnology Center.
EncepHeal Therapeutics is headquartered in Winston Salem, United States.
EncepHeal Therapeutics enhances the development of first-in-class medicines to improve treatment of mental health disorders.
EncepHeal Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EncepHeal Therapeutics — Funding & Investors." VCBacked, July 30, 2021, https://www.vcbacked.co/company/encepheal-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). EncepHeal Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/encepheal-therapeutics
{{cite web |title=EncepHeal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/encepheal-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated